Prognostic Value of Chemotherapy Response Score (CRS) Assessed on the Adnexa in Ovarian High-Grade Serous Carcinoma: A Systematic Review and Meta-Analysis

Background: chemotherapy response score (CRS) is widely used to assess the response of ovarian high-grade serous carcinoma (HGSC) to chemotherapy and is based on pathological examination of omental specimens. We aimed to assess the prognostic value of CRS assessed on the uterine adnexa. Methods: a s...

Descripción completa

Detalles Bibliográficos
Autores principales: Santoro, Angela, Travaglino, Antonio, Inzani, Frediano, Straccia, Patrizia, Arciuolo, Damiano, Valente, Michele, D’Alessandris, Nicoletta, Scaglione, Giulia, Angelico, Giuseppe, Piermattei, Alessia, Cianfrini, Federica, Raffone, Antonio, Zannoni, Gian Franco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946962/
https://www.ncbi.nlm.nih.gov/pubmed/35328186
http://dx.doi.org/10.3390/diagnostics12030633

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946962/
https://www.ncbi.nlm.nih.gov/pubmed/35328186
http://dx.doi.org/10.3390/diagnostics12030633

Ejemplares similares